Similar Posts
Doctors Still Waiting to Test Buprenorphine’s Promise
Join Together Online January 21, 2003 While 616 physicians nationwide are now authorized to prescribe buprenorphine, its widespread use is still an issue, the Baltimore Sun reported on January 15. Product availability is the first problem. Despite receiving FDA approval in October, the manufacturer did not ship the product to pharmaceutical warehouses until last week….
NAMA Advocate
NAMA Advocate Newsletter Archive Summer 2001 (Vol1 No.1) Fall 2001 (Vol1 No.2) pdf format only Spring/Summer (Vol1 No.3) pdf format only pdf files can only be read with ADOBE Acrobat reader. Available for free at: http://www.adobe.com/products/acrobat/
Figure 3 The Methadone Molecule
Contents The Pharmacology of Opioids Cont. Back Education Series Number 5.1 February 2001 (Revised) Part 2 continued Figure 3 The Methadone Molecule. The two dimensional representation of the methadone molecule is very different from that of morphine. However, molecules are three dimensional and the methadone molecule bends into a structure that is very…
What is NAMA NOT?
NAMA is not an organization of apologists for what passes for methadone maintenance treatment in the United States today. Most MMT programs do not even come close to practicing the treatment modality created by Drs Dole and Nyswander three decades ago, and even the best programs are severely hampered by senseless regulation and by the…
national alliance of methadone advocates
Whereas, substance use disorders are a serious and treatable public health problem affecting thousand of Americans of all ages, races, ethnic backgrounds and having huge medical ,societal and economic costs; and Whereas, methadone treatment is the “gold standard” for all drug and alcohol treatments and yet is misunderstood because of years of prejudice and…
CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-2
Responsible Medication Assisted Treatment (MAT) Advocacy First the ground rules! In every thing NAMA-R does the rights and dignity of the individual patient take precedence. It is never, ever, OK to violate that rule no matter how important the issue. NAMA-R has not and will never serve as an apologist for poor treatment. Everyone whether…